Extramural Funding
Overall, NCI obligations for its extramural program, which includes grants and contracts, totaled $5.41 billion in fiscal year 2023.
- Obligations for grants totaled approximately 82.8% of extramural funding
- Obligations for contracts totaled approximately 17.2% of extramural funding
Obligations on this page include fiscal year 2023 Cancer Moonshot℠ funding and excludes fiscal years 2022 through 2017 Cures Moonshot carryover obligations.
| Mechanism | Amount | Percent |
|---|---|---|
| Research & Development (R&D) Contracts | $899,070,171 | 16.6% |
| Buildings and Facilities | $30,000,000 | 0.6% |
| Construction Contracts | $0 | 0.0% |
| Subtotal Contracts | $929,070,171 | 17.2% |
| Research Project Grants (RPGs) | $3,145,236,780 | 58.1% |
| Cancer Centers/Specialized Centers/SPORES | $624,438,597 | 11.5% |
| NRSA | $90,324,558 | 1.7% |
| Other Research Grants | $621,500,774 | 11.5% |
| Subtotal Grants | $4,481,500,709 | 82.8% |
| Total Extramural Funds | $5,410,570,880 | 100.0% |
| Intramural/RMS Funds | $1,776,330,616 | |
| Total NCI | $7,186,901,496 | |